Name: Global Sympathomimetic Agents Market Insights and Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.6 (249 reviews)

Global Sympathomimetic Agents Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Extent Research has published a new report titled “Global Sympathomimetic Agents Market ‑ By Product (Dobutamine, Dopamine, Ephedrine, Epinephrine, Isoproterenol, Mephentermine, Metaraminol, Methoxamine, Norepinephrine, Phenylephrine, ), By Application (Anaphylaxis, Cardiac Arrest, Others, ), and Regional Analysis for Forecast period 2026 to 2035.” The important parameters that are covered within this report are market value, market share, segments, regional analysis, and the company profiles of the manufacturers operating in the Sympathomimetic Agents market. The global report on the Sympathomimetic Agents market will provide the clients with detailed figures regarding the market which was valued in the historical timeline 2015 to 2025 and the forecast values from 2026 to 2035. The research analysts have also found the most precise CAGR for the Sympathomimetic Agents market growth and have also summed the growth factors that will trigger the growth of the Sympathomimetic Agents market during the forecast period. The report offers the latest technological advancements, market trends, and the opportunities that will turn as a breakthrough for the market players to strategically design their future plans. The Sympathomimetic Agents market dynamics that are discussed in the report includes drivers, restraints, opportunities, challenges, and the target audience for the market.

Data provided by Extent Research. Source: https://www.extentresearch.com/sympathomimetic-agents-market

In addition, the Sympathomimetic Agents market includes by Product type Dobutamine, Dopamine, Ephedrine, Epinephrine, Isoproterenol, Mephentermine, Metaraminol, Methoxamine, Norepinephrine, Phenylephrine, , by Application Anaphylaxis, Cardiac Arrest, Others, . The major regions that are focused in the report are Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. The market analysis is not just restricted to the region but also includes country-wise market analysis.

Sympathomimetic Agents Market: Regional Analysis

Asia-Pacific (China, Japan, India, Australia, and Rest of Asia Pacific countries)
Europe (Germany, Russia, UK, Italy, France, and Rest of European countries)
North America (The United States, Mexico, Canada, and Rest of North American countries)
South America (Brazil and Rest of Latin American countries)
The Middle East and Africa (GCC Countries, Egypt, and Rest of MEA countries)

In addition, some of the major market players that are enlisted in the report include Pfizer, Sanofi, Novartis, Sterimax, Bedford Pharmaceuticals, Teva, Amneal Biosciences, Baxter Laboratories, Hikma Pharmaceuticals, Amphastar Pharmaceuticals, Marathon Pharmaceuticals, Bausch Health Companies, Sterling-Winthrop, Cipla USA, Nexus Pharmaceuticals, Mylan, Impax, ALK Abello, Lincoln Medical, Amphastar, Emerade, Grand Pharma, Harvest Pharmaceuticals, Merit Pharmaceutical, Tianjin Jinyao Group, . An extensive analysis of the supply and demand pattern analysis and the competitive landscape among the market players is included in the global Sympathomimetic Agents market report. The Sympathomimetic Agents market report also includes manufacturing data details such as gross profit, shipment, and business distribution which can aid the consumer to know about the competitive landscape.

Report Scope and Market Segmentation

ATTRIBUTES	Global Sympathomimetic Agents Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Sympathomimetic Agents Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sympathomimetic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Dobutamine
        1.2.3 Dopamine
        1.2.4 Ephedrine
        1.2.5 Epinephrine
        1.2.6 Isoproterenol
        1.2.7 Mephentermine
        1.2.8 Metaraminol
        1.2.9 Methoxamine
        1.2.10 Norepinephrine
        1.2.11 Phenylephrine
    1.3 Market by Application
        1.3.1 Global Sympathomimetic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Anaphylaxis
        1.3.3 Cardiac Arrest
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Sympathomimetic Agents Market Perspective (2017-2035)
    2.2 Sympathomimetic Agents Growth Trends by Region
        2.2.1 Sympathomimetic Agents Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Sympathomimetic Agents Historic Market Size by Region (2017-2022)
        2.2.3 Sympathomimetic Agents Forecasted Market Size by Region (2023-2035)
    2.3 Sympathomimetic Agents Market Dynamics
        2.3.1 Sympathomimetic Agents Industry Trends
        2.3.2 Sympathomimetic Agents Market Drivers
        2.3.3 Sympathomimetic Agents Market Challenges
        2.3.4 Sympathomimetic Agents Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Sympathomimetic Agents Players by Revenue
        3.1.1 Global Top Sympathomimetic Agents Players by Revenue (2017-2022)
        3.1.2 Global Sympathomimetic Agents Revenue Market Share by Players (2017-2022)
    3.2 Global Sympathomimetic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Sympathomimetic Agents Revenue
    3.4 Global Sympathomimetic Agents Market Concentration Ratio
        3.4.1 Global Sympathomimetic Agents Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sympathomimetic Agents Revenue in 2021
    3.5 Sympathomimetic Agents Key Players Head office and Area Served
    3.6 Key Players Sympathomimetic Agents Product Solution and Service
    3.7 Date of Enter into Sympathomimetic Agents Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Sympathomimetic Agents Breakdown Data by Type
    4.1 Global Sympathomimetic Agents Historic Market Size by Type (2017-2022)
    4.2 Global Sympathomimetic Agents Forecasted Market Size by Type (2023-2035)
5 Sympathomimetic Agents Breakdown Data by Application
    5.1 Global Sympathomimetic Agents Historic Market Size by Application (2017-2022)
    5.2 Global Sympathomimetic Agents Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Sympathomimetic Agents Market Size (2017-2035)
    6.2 North America Sympathomimetic Agents Market Size by Type
        6.2.1 North America Sympathomimetic Agents Market Size by Type (2017-2022)
        6.2.2 North America Sympathomimetic Agents Market Size by Type (2023-2035)
        6.2.3 North America Sympathomimetic Agents Market Share by Type (2017-2035)
    6.3 North America Sympathomimetic Agents Market Size by Application
        6.3.1 North America Sympathomimetic Agents Market Size by Application (2017-2022)
        6.3.2 North America Sympathomimetic Agents Market Size by Application (2023-2035)
        6.3.3 North America Sympathomimetic Agents Market Share by Application (2017-2035)
    6.4 North America Sympathomimetic Agents Market Size by Country
        6.4.1 North America Sympathomimetic Agents Market Size by Country (2017-2022)
        6.4.2 North America Sympathomimetic Agents Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Sympathomimetic Agents Market Size (2017-2035)
    7.2 Europe Sympathomimetic Agents Market Size by Type
        7.2.1 Europe Sympathomimetic Agents Market Size by Type (2017-2022)
        7.2.2 Europe Sympathomimetic Agents Market Size by Type (2023-2035)
        7.2.3 Europe Sympathomimetic Agents Market Share by Type (2017-2035)
    7.3 Europe Sympathomimetic Agents Market Size by Application
        7.3.1 Europe Sympathomimetic Agents Market Size by Application (2017-2022)
        7.3.2 Europe Sympathomimetic Agents Market Size by Application (2023-2035)
        7.3.3 Europe Sympathomimetic Agents Market Share by Application (2017-2035)
    7.4 Europe Sympathomimetic Agents Market Size by Country
        7.4.1 Europe Sympathomimetic Agents Market Size by Country (2017-2022)
        7.4.2 Europe Sympathomimetic Agents Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Sympathomimetic Agents Market Size (2017-2035)
    8.2 Asia-Pacific Sympathomimetic Agents Market Size by Type
        8.2.1 Asia-Pacific Sympathomimetic Agents Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Sympathomimetic Agents Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Sympathomimetic Agents Market Share by Type (2017-2035)
    8.3 Asia-Pacific Sympathomimetic Agents Market Size by Application
        8.3.1 Asia-Pacific Sympathomimetic Agents Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Sympathomimetic Agents Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Sympathomimetic Agents Market Share by Application (2017-2035)
    8.4 Asia-Pacific Sympathomimetic Agents Market Size by Region
        8.4.1 Asia-Pacific Sympathomimetic Agents Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Sympathomimetic Agents Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Sympathomimetic Agents Market Size (2017-2035)
    9.2 Latin America Sympathomimetic Agents Market Size by Type
        9.2.1 Latin America Sympathomimetic Agents Market Size by Type (2017-2022)
        9.2.2 Latin America Sympathomimetic Agents Market Size by Type (2023-2035)
        9.2.3 Latin America Sympathomimetic Agents Market Share by Type (2017-2035)
    9.3 Latin America Sympathomimetic Agents Market Size by Application
        9.3.1 Latin America Sympathomimetic Agents Market Size by Application (2017-2022)
        9.3.2 Latin America Sympathomimetic Agents Market Size by Application (2023-2035)
        9.3.3 Latin America Sympathomimetic Agents Market Share by Application (2017-2035)
    9.4 Latin America Sympathomimetic Agents Market Size by Country
        9.4.1 Latin America Sympathomimetic Agents Market Size by Country (2017-2022)
        9.4.2 Latin America Sympathomimetic Agents Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Sympathomimetic Agents Market Size (2017-2035)
    10.2 Middle East & Africa Sympathomimetic Agents Market Size by Type
        10.2.1 Middle East & Africa Sympathomimetic Agents Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Sympathomimetic Agents Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Sympathomimetic Agents Market Share by Type (2017-2035)
    10.3 Middle East & Africa Sympathomimetic Agents Market Size by Application
        10.3.1 Middle East & Africa Sympathomimetic Agents Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Sympathomimetic Agents Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Sympathomimetic Agents Market Share by Application (2017-2035)
    10.4 Middle East & Africa Sympathomimetic Agents Market Size by Country
        10.4.1 Middle East & Africa Sympathomimetic Agents Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Sympathomimetic Agents Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Sympathomimetic Agents Introduction
        11.1.4 Pfizer Revenue in Sympathomimetic Agents Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Sympathomimetic Agents Introduction
        11.2.4 Sanofi Revenue in Sympathomimetic Agents Business (2017-2022)
        11.2.5 Sanofi Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Sympathomimetic Agents Introduction
        11.3.4 Novartis Revenue in Sympathomimetic Agents Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Sterimax
        11.4.1 Sterimax Company Details
        11.4.2 Sterimax Business Overview
        11.4.3 Sterimax Sympathomimetic Agents Introduction
        11.4.4 Sterimax Revenue in Sympathomimetic Agents Business (2017-2022)
        11.4.5 Sterimax Recent Developments
    11.5 Bedford Pharmaceuticals
        11.5.1 Bedford Pharmaceuticals Company Details
        11.5.2 Bedford Pharmaceuticals Business Overview
        11.5.3 Bedford Pharmaceuticals Sympathomimetic Agents Introduction
        11.5.4 Bedford Pharmaceuticals Revenue in Sympathomimetic Agents Business (2017-2022)
        11.5.5 Bedford Pharmaceuticals Recent Developments
    11.6 Teva
        11.6.1 Teva Company Details
        11.6.2 Teva Business Overview
        11.6.3 Teva Sympathomimetic Agents Introduction
        11.6.4 Teva Revenue in Sympathomimetic Agents Business (2017-2022)
        11.6.5 Teva Recent Developments
    11.7 Amneal Biosciences
        11.7.1 Amneal Biosciences Company Details
        11.7.2 Amneal Biosciences Business Overview
        11.7.3 Amneal Biosciences Sympathomimetic Agents Introduction
        11.7.4 Amneal Biosciences Revenue in Sympathomimetic Agents Business (2017-2022)
        11.7.5 Amneal Biosciences Recent Developments
    11.8 Baxter Laboratories
        11.8.1 Baxter Laboratories Company Details
        11.8.2 Baxter Laboratories Business Overview
        11.8.3 Baxter Laboratories Sympathomimetic Agents Introduction
        11.8.4 Baxter Laboratories Revenue in Sympathomimetic Agents Business (2017-2022)
        11.8.5 Baxter Laboratories Recent Developments
    11.9 Hikma Pharmaceuticals
        11.9.1 Hikma Pharmaceuticals Company Details
        11.9.2 Hikma Pharmaceuticals Business Overview
        11.9.3 Hikma Pharmaceuticals Sympathomimetic Agents Introduction
        11.9.4 Hikma Pharmaceuticals Revenue in Sympathomimetic Agents Business (2017-2022)
        11.9.5 Hikma Pharmaceuticals Recent Developments
    11.10 Amphastar Pharmaceuticals
        11.10.1 Amphastar Pharmaceuticals Company Details
        11.10.2 Amphastar Pharmaceuticals Business Overview
        11.10.3 Amphastar Pharmaceuticals Sympathomimetic Agents Introduction
        11.10.4 Amphastar Pharmaceuticals Revenue in Sympathomimetic Agents Business (2017-2022)
        11.10.5 Amphastar Pharmaceuticals Recent Developments
    11.11 Marathon Pharmaceuticals
        11.11.1 Marathon Pharmaceuticals Company Details
        11.11.2 Marathon Pharmaceuticals Business Overview
        11.11.3 Marathon Pharmaceuticals Sympathomimetic Agents Introduction
        11.11.4 Marathon Pharmaceuticals Revenue in Sympathomimetic Agents Business (2017-2022)
        11.11.5 Marathon Pharmaceuticals Recent Developments
    11.12 Bausch Health Companies
        11.12.1 Bausch Health Companies Company Details
        11.12.2 Bausch Health Companies Business Overview
        11.12.3 Bausch Health Companies Sympathomimetic Agents Introduction
        11.12.4 Bausch Health Companies Revenue in Sympathomimetic Agents Business (2017-2022)
        11.12.5 Bausch Health Companies Recent Developments
    11.13 Sterling-Winthrop
        11.13.1 Sterling-Winthrop Company Details
        11.13.2 Sterling-Winthrop Business Overview
        11.13.3 Sterling-Winthrop Sympathomimetic Agents Introduction
        11.13.4 Sterling-Winthrop Revenue in Sympathomimetic Agents Business (2017-2022)
        11.13.5 Sterling-Winthrop Recent Developments
    11.14 Cipla USA
        11.14.1 Cipla USA Company Details
        11.14.2 Cipla USA Business Overview
        11.14.3 Cipla USA Sympathomimetic Agents Introduction
        11.14.4 Cipla USA Revenue in Sympathomimetic Agents Business (2017-2022)
        11.14.5 Cipla USA Recent Developments
    11.15 Nexus Pharmaceuticals
        11.15.1 Nexus Pharmaceuticals Company Details
        11.15.2 Nexus Pharmaceuticals Business Overview
        11.15.3 Nexus Pharmaceuticals Sympathomimetic Agents Introduction
        11.15.4 Nexus Pharmaceuticals Revenue in Sympathomimetic Agents Business (2017-2022)
        11.15.5 Nexus Pharmaceuticals Recent Developments
    11.16 Mylan
        11.16.1 Mylan Company Details
        11.16.2 Mylan Business Overview
        11.16.3 Mylan Sympathomimetic Agents Introduction
        11.16.4 Mylan Revenue in Sympathomimetic Agents Business (2017-2022)
        11.16.5 Mylan Recent Developments
    11.17 Impax
        11.17.1 Impax Company Details
        11.17.2 Impax Business Overview
        11.17.3 Impax Sympathomimetic Agents Introduction
        11.17.4 Impax Revenue in Sympathomimetic Agents Business (2017-2022)
        11.17.5 Impax Recent Developments
    11.18 ALK Abello
        11.18.1 ALK Abello Company Details
        11.18.2 ALK Abello Business Overview
        11.18.3 ALK Abello Sympathomimetic Agents Introduction
        11.18.4 ALK Abello Revenue in Sympathomimetic Agents Business (2017-2022)
        11.18.5 ALK Abello Recent Developments
    11.19 Lincoln Medical
        11.19.1 Lincoln Medical Company Details
        11.19.2 Lincoln Medical Business Overview
        11.19.3 Lincoln Medical Sympathomimetic Agents Introduction
        11.19.4 Lincoln Medical Revenue in Sympathomimetic Agents Business (2017-2022)
        11.19.5 Lincoln Medical Recent Developments
    11.20 Amphastar
        11.20.1 Amphastar Company Details
        11.20.2 Amphastar Business Overview
        11.20.3 Amphastar Sympathomimetic Agents Introduction
        11.20.4 Amphastar Revenue in Sympathomimetic Agents Business (2017-2022)
        11.20.5 Amphastar Recent Developments
    11.21 Emerade
        11.21.1 Emerade Company Details
        11.21.2 Emerade Business Overview
        11.21.3 Emerade Sympathomimetic Agents Introduction
        11.21.4 Emerade Revenue in Sympathomimetic Agents Business (2017-2022)
        11.21.5 Emerade Recent Developments
    11.22 Grand Pharma
        11.22.1 Grand Pharma Company Details
        11.22.2 Grand Pharma Business Overview
        11.22.3 Grand Pharma Sympathomimetic Agents Introduction
        11.22.4 Grand Pharma Revenue in Sympathomimetic Agents Business (2017-2022)
        11.22.5 Grand Pharma Recent Developments
    11.23 Harvest Pharmaceuticals
        11.23.1 Harvest Pharmaceuticals Company Details
        11.23.2 Harvest Pharmaceuticals Business Overview
        11.23.3 Harvest Pharmaceuticals Sympathomimetic Agents Introduction
        11.23.4 Harvest Pharmaceuticals Revenue in Sympathomimetic Agents Business (2017-2022)
        11.23.5 Harvest Pharmaceuticals Recent Developments
    11.24 Merit Pharmaceutical
        11.24.1 Merit Pharmaceutical Company Details
        11.24.2 Merit Pharmaceutical Business Overview
        11.24.3 Merit Pharmaceutical Sympathomimetic Agents Introduction
        11.24.4 Merit Pharmaceutical Revenue in Sympathomimetic Agents Business (2017-2022)
        11.24.5 Merit Pharmaceutical Recent Developments
    11.25 Tianjin Jinyao Group
        11.25.1 Tianjin Jinyao Group Company Details
        11.25.2 Tianjin Jinyao Group Business Overview
        11.25.3 Tianjin Jinyao Group Sympathomimetic Agents Introduction
        11.25.4 Tianjin Jinyao Group Revenue in Sympathomimetic Agents Business (2017-2022)
        11.25.5 Tianjin Jinyao Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Sympathomimetic Agents Market